A NOVEL BREAST CANCER VACCINE USING IMMUNOSTIMULATORY PEPTIDES

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的目的是确定乳腺癌患者是否有能够与来自肿瘤相关抗原和免疫刺激多肽的多肽发生反应的淋巴细胞。所有实验都将在体外进行，从患者的外周血液中分离出淋巴细胞。这将为乳腺癌患者的新疫苗设计提供基础。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The goal of this study is to determine whether patients with breast cancer possess lymphocytes able to react with peptides, derived from tumor-associated antigens in conjunction with immunostimulatory peptides. All experiments will be performed in vitro, with lymphocytes isolated from patients' peripheral blood. This will provide the basis for a new vaccine design for patients with breast cancer.